The Dustin lab at the Kennedy Institute of Rheumatology, University of Oxford has a 2 year industry funded PDRA position open for applications. It is funded by the Biotech company Evolveimmune to study the role of CD2-CD58 interactions and the ability to target this costimulatory pathway using multispecific T cell engagers. For further information, please visit:

(closing date for applications: 4 August 2023)